John V. Crues Sells 20,000 Shares of RadNet Inc. (RDNT) Stock

RadNet Inc. (NASDAQ:RDNT) Director John V. Crues sold 20,000 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $10.08, for a total transaction of $201,600.00. Following the completion of the sale, the director now directly owns 563,781 shares of the company’s stock, valued at $5,682,912.48. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of RadNet Inc. (RDNT) traded down $0.40 on Friday, hitting $10.10. 283,782 shares of the stock traded hands, compared to its average volume of 207,137. RadNet Inc. has a 52-week low of $5.25 and a 52-week high of $11.90. The stock has a market cap of $478.62, a PE ratio of 32.67, a PEG ratio of 3.29 and a beta of 0.87. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, hitting the consensus estimate of $0.12. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The firm had revenue of $227.60 million during the quarter, compared to analysts’ expectations of $232.84 million. During the same quarter in the prior year, the company earned $0.11 EPS. The company’s revenue was up 1.3% compared to the same quarter last year. equities analysts expect that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the company. Geode Capital Management LLC lifted its position in shares of RadNet by 6.6% in the 1st quarter. Geode Capital Management LLC now owns 274,192 shares of the medical research company’s stock worth $1,617,000 after purchasing an additional 16,924 shares during the period. Vanguard Group Inc. lifted its position in shares of RadNet by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 1,233,623 shares of the medical research company’s stock worth $7,278,000 after purchasing an additional 30,054 shares during the period. Wedge Capital Management L L P NC purchased a new stake in shares of RadNet in the 3rd quarter worth approximately $403,000. Schwab Charles Investment Management Inc. lifted its position in shares of RadNet by 18.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 163,032 shares of the medical research company’s stock worth $1,264,000 after purchasing an additional 25,300 shares during the period. Finally, TIAA CREF Investment Management LLC lifted its position in shares of RadNet by 19.7% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 124,612 shares of the medical research company’s stock worth $966,000 after purchasing an additional 20,520 shares during the period. 53.31% of the stock is owned by hedge funds and other institutional investors.

RDNT has been the subject of several research reports. Zacks Investment Research cut shares of RadNet from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Jefferies Group raised shares of RadNet from a “hold” rating to a “buy” rating and boosted their price objective for the company from $7.00 to $12.00 in a research report on Tuesday, August 22nd. BidaskClub raised shares of RadNet from a “buy” rating to a “strong-buy” rating in a research report on Thursday, August 24th. Finally, TheStreet cut shares of RadNet from a “b-” rating to a “c” rating in a research report on Friday, October 27th.

WARNING: This article was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/12/01/john-v-crues-sells-20000-shares-of-radnet-inc-rdnt-stock.html.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply